SCHEMBL29488481

SCHEMBL29488481

O=C(CCCC/C=C(\COc1cccc2ccccc12)C(=O)NCc1cccs1)NO

nearest known ligand 0.45

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ GAA P10253 2/20 0.45
▸ POLB P06746 1/20 0.45
▸ CYP1A2 P05177 1/20 0.45
▸ CYP3A4 P08684 1/20 0.45
▸ CYP2C19 P33261 1/20 0.45
▸ USP2 O75604 1/20 0.44
▸ KMT2A Q03164 2/20 0.42
▸ HPGD P15428 4/20 0.41
▸ ALDH1A1 P00352 4/20 0.40
▸ KDM4E B2RXH2 4/20 0.40
▸ TDP1 Q9NUW8 1/20 0.40
▸ MAPT P10636 3/20 0.40
▸ MEN1 O00255 1/20 0.40
▸ OGG1 O15527 1/20 0.40
▸ SMN1; SMN2 Q16637 1/20 0.38
▸ MAPK1 P28482 1/20 0.38
▸ LMNA P02545 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1305360 1.00 GAA (0.45) GAAPOLBCYP1A2CYP3A4CYP2C19
SCHEMBL1305354 1.00 GAA (0.45) GAAPOLBCYP1A2CYP3A4CYP2C19
SCHEMBL1308416 0.91 HPGD (0.46) GAAPOLBCYP1A2CYP3A4CYP2C19
SCHEMBL1308420 0.91 HPGD (0.46) GAAPOLBCYP1A2CYP3A4CYP2C19
SCHEMBL1305938 0.90 GAA (0.47) GAAPOLBCYP1A2CYP3A4CYP2C19
SCHEMBL1305937 0.90 GAA (0.47) GAAPOLBCYP1A2CYP3A4CYP2C19
SCHEMBL1306560 0.85 CYP1A2 (0.46) GAAPOLBCYP1A2CYP3A4CYP2C19
SCHEMBL1306554 0.85 CYP1A2 (0.46) GAAPOLBCYP1A2CYP3A4CYP2C19
SCHEMBL1305788 0.84 HPGD (0.49) GAAPOLBCYP1A2CYP3A4CYP2C19
SCHEMBL1305785 0.84 HPGD (0.49) GAAPOLBCYP1A2CYP3A4CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-114340672-A Pharmaceutical composition comprising an HDAC inhibitor and an anti-PD 1 antibody or an anti-PD-L1 antibody 晶体基因技术株式会社 2022-04-12 — — CN claimed
CN-114340672-A Pharmaceutical composition comprising an HDAC inhibitor and an anti-PD 1 antibody or an anti-PD-L1 antibody 晶体基因技术株式会社 2022-04-12 — — CN disclosed
CN-110740989-B Pharmaceutically acceptable salts of alkylcarbamoylnaphthoxyoctenoylhydroxyamides or derivatives thereof and process for preparing the same 晶体基因技术株式会社 2022-03-08 — — CN disclosed
Send feedback